Results 111 to 120 of about 159,323 (346)
Best therapy for primary amyloidosis, a not-yet-solved question [PDF]
Arnaud Jaccard +3 more
openalex +1 more source
Pathological Aging in Africans: A Benign Form of Cerebral Amyloidosis vs. Pre‐Clinical Alzheimer's Disease? [PDF]
Dennis W. Dickson
openalex +1 more source
What's New? Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic precursor to multiple myeloma, sharing substantial genetic features with overt malignancy. Given evidence implicating autophagy in myeloma risk, this study examined whether genetic variations in autophagy‐related genes influence MGUS susceptibility.
José Manuel Sánchez‐Maldonado +54 more
wiley +1 more source
ABSTRACT Alzheimer's disease (AD) is one of the most common neurological disorders affecting older adults, with approximately 7.2 million cases only in the United States. This number is projected to increase to 13.8 million in the United States by 2060, leading to increased expenditures for healthcare, long‐term care and hospice services. Consequently,
Valentina Zecca +3 more
wiley +1 more source
Ethnicity in systemic AL amyloidosis may impact risk stratification
Not available.
Jahanzaib Khwaja +12 more
doaj +1 more source
ABSTRACT Background Poor cardiac MR image quality can prompt repeat examinations and hinder clinical decision‐making. Purpose To evaluate whether pre‐imaging clinical information, extracted using a large language model (LLM), is independently associated with cardiac MR image quality. Study Type Retrospective.
Hong Yu +6 more
wiley +1 more source
Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis
Background/Objectives: Antibody light chains form amyloid fibrils that lead to progressive tissue damage in amyloid light chain (AL) amyloidosis. The properties of each patient’s unique light chain appear to determine its propensity to form amyloid.
Gareth J. Morgan +4 more
doaj +1 more source
Outcomes of heart failure with preserved ejection fraction (HFpEF) in patients with and without cardiac amyloidosis: analysis from 2016–2019 national inpatient sample [PDF]
Soumya Kambalapalli +3 more
openalex +1 more source

